Preprint Brief Report Version 1 This version is not peer-reviewed

An Anti-Inflammatory Azaphenothiazine Inhibits Interferon β Expression and CXCL10 Production in KERTr Cells

Version 1 : Received: 13 September 2018 / Approved: 14 September 2018 / Online: 14 September 2018 (12:42:52 CEST)

How to cite: Strzadala, L.; Fiedorowicz, A.; Wysokinska, E.; Ziolo, E.; Grudzien, M.; Jelen, M.; Pluta, K.; Morak-Mlodawska, B.; Zimecki, M.; Kalas, W. An Anti-Inflammatory Azaphenothiazine Inhibits Interferon β Expression and CXCL10 Production in KERTr Cells. Preprints 2018, 2018090264 (doi: 10.20944/preprints201809.0264.v1). Strzadala, L.; Fiedorowicz, A.; Wysokinska, E.; Ziolo, E.; Grudzien, M.; Jelen, M.; Pluta, K.; Morak-Mlodawska, B.; Zimecki, M.; Kalas, W. An Anti-Inflammatory Azaphenothiazine Inhibits Interferon β Expression and CXCL10 Production in KERTr Cells. Preprints 2018, 2018090264 (doi: 10.20944/preprints201809.0264.v1).

Abstract

An azaphenothiazine derivative, 6-chloroethylureidoethyldiquino[3,2-b;2’,3’-e][1,4]thiazine (DQT) has recently been shown to exhibit immunosuppressive activities in mouse models. It also inhibited the expression of CXCL10 at the protein level, at non-toxic concentrations, in the culture of KERTr cells treated with double-stranded RNA, poly(I:C). In this report, we demonstrated that DQT inhibits the transcription of the CXCL10 gene. Although CXCL10 is an IFNγ-inducible protein, we found that the CXCL10 protein was induced without the detectable release of IFNγ or IκB degradation. Hence, we concluded that IFNγ or NFκB were not involved in the regulation of the CXCL10 gene in KERTr cells transfected with poly(I:C) as well as in the inhibitory activity of DQT. On the other hand, we found that IFNβ was induced under the same conditions and its expression was inhibited by DQT. Kinetic analysis showed that an increase in IFNβ concentrations occurred 4-8 h after poly(I:C) treatment, while the concentration of CXCL10 was undetectable at that time and started to increase later, when IFNβ reached high levels. Therefore, DQT may be regarded as a new promising inhibitor of IFNβ expression and IFNβ-dependent downstream genes and proteins, e.g., CXCL10 chemokine, which is implicated in pathogenesis of autoimmune diseases.

Subject Areas

azaphenothiazine; anti-inflammatory activity; CXCL10; KERTr cells; keratinocytes; IFNβ; TLR3;

Readers' Comments and Ratings (0)

Leave a public comment
Send a private comment to the author(s)
Rate this article
Views 0
Downloads 0
Comments 0
Metrics 0
Leave a public comment

×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.